These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11521791)

  • 1. The revitalization of thalidomide.
    Thomas DA; Kantarjian HM
    Ann Oncol; 2001 Jul; 12(7):885-6. PubMed ID: 11521791
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent studies on the thalidomide and its derivatives.
    Łączkowski KZ; Baranowska-Łączkowska A
    Future Med Chem; 2018 Sep; 10(18):2133-2136. PubMed ID: 30088422
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide.
    Waldman AR
    Clin J Oncol Nurs; 2000; 4(2):99-100. PubMed ID: 11107384
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide--a revival story.
    Raje N; Anderson K
    N Engl J Med; 1999 Nov; 341(21):1606-9. PubMed ID: 10564693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thalidomide: the revival].
    Grosbois B; Duguet C
    Rev Med Interne; 2001 Jan; 22(1):5-7. PubMed ID: 11218298
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma.
    D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS
    Semin Oncol; 2001 Dec; 28(6):597-601. PubMed ID: 11740816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide. A new beginning.
    Valorie AM
    Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
    [No Abstract]   [Full Text] [Related]  

  • 9. Is thalidomide a true anti-angiogenic molecule in multiple myeloma?
    Ribatti D; Vacca A
    Haematologica; 2002 Apr; 87(4):344-5. PubMed ID: 11940476
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in cancer medicine.
    Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
    Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative oncology: thalidomide.
    Prommer EE
    Am J Hosp Palliat Care; 2010 May; 27(3):198-204. PubMed ID: 19843880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of thalidomide in the treatment of cancer.
    Rajkumar SV
    Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide in the treatment of relapsed multiple myeloma.
    Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
    Mayo Clin Proc; 2000 Sep; 75(9):897-901. PubMed ID: 10994824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of thalidomide and its IMiD derivatives as anticancer agents.
    Bartlett JB; Dredge K; Dalgleish AG
    Nat Rev Cancer; 2004 Apr; 4(4):314-22. PubMed ID: 15057291
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
    Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB
    Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide in the treatment of multiple myeloma.
    Rajkumar SV
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):20-8. PubMed ID: 12113124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thalidomide--new prospective therapy in oncology].
    Pałgan K; Pałgan I
    Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma.
    Ribatti D; Vacca A
    Ann Hematol; 2003 Apr; 82(4):262. PubMed ID: 12707735
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.